Skip to main content

Table 3 Laboratory tests and diagnostic images

From: Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin – propensity score matching study

 

No Match

Match

Total population n= 505

Rivaroxaban n= 220

Warfarin n= 285

p value

Total population n= 418

Rivaroxaban n= 209

Warfarin n= 209

p value

D-dimer, m(SD)

4.5 (3.37)

4.3 (3.25)

4.6 (3.48)

0.34

4.6 (3.38)

4.4 (3.19)

4.9 (3.59)

0.16

Troponin, m(SD)

0.2 (0.62)

0.2 (0.71)

0.2 (0.53)

0.92

0.2 (0.69)

0.2 (0.74)

0.2 (0.63)

0.63

chest x-ray; n (%)

207 (41)

89 (40.5)

118 (41.4)

0.83

161 (38.5)

81 (38.8)

80 (38.3)

0.92

Hilar artery amputation, n (%)

5 (1)

2 (0.9)

3 (1.1)

0.87

4 (1)

2 (1)

2 (1)

1.00

Consolidation due to PI, n (%)

14 (100)

6 (100)

8 (100)

0.96

12 (100)

6 (100)

6 (100)

1.00

Consolidation without to PI, n (%)

32 (6.3)

16 (7.3)

16 (5.6)

0.45

26 (6.2)

14 (6.7)

12 (5.7)

0.69

Pulmonary edema, n (%)

12 (2.4)

4 (1.8)

8 (2.8)

0.47

11 (2.6)

4 (1.9)

7 (3.3)

0.36

Echocardiogram, n (%)

150 (29.7)

73 (33.2)

77 (27)

0.13

123 (29.4)

65 (31.1)

58 (27.8)

0.45

TAPSE, n (%)

1.8 (0.41)

1.8 (0.39)

1.8 (0.44)

0.77

1.8 (0.43)

1.8 (0.41)

1.8 (0.46)

0.20

Pressure overload of right cavities, n (%)

18 (3.6)

10 (4.5)

8 (2.8)

0.30

15 (3.6)

7 (3.3)

8 (3.8)

0.79

paradoxical movement, n (%)

2 (0.4)

1 (0.5)

1 (0.4)

0.85

2 (0.5)

1 (0.5)

1 (0.5)

1.00

Deviation of the interventricular septum, n (%)

3 (0.6)

2 (0.9)

1 (0.4)

0.42

3 (0.7)

2 (1)

1 (0.5)

0.56

DVT diagnosis, n (%)

265 (52.5)

111 (50.5)

154 (54)

0.27

219 (52.4)

108 (51.7)

111 (53.1)

0.48

PE with DVT diagnosis, n (%)

54 (10.7)

20 (9.1)

34 (11.9)

0.16

40 (9.6)

17 (8.1)

23 (11)

0.34

PE diagnosis, n (%)

186 (36.8)

89 (40.5)

97 (34)

0.24

159 (38)

84 (40.2)

75 (35.9)

0.30

  1. m average, SD standard deviation, PI Pulmonary infarction, TAPSE Tricuspid Annular Plane Systolic Excursion, PE Pulmonary embolism, DVT Deep vein thrombosis